[1]The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977; 56:786-94.
[2]2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in c ollaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Writing on Behal f of the 2004 Writing Committee. Circulation. 2008; 117:296-329.
[3]Cardiac protection during acute myocardial infarction: where do we stand in 2004?. J Am Coll Cardiol. 2004; 44:276-86.
[4]Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999; 318:1730-7.
[5]Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004; 25:1341-62.
[6]Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol. Arch Intern Med. 1972; 129:780-9.
[7]Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. N Engl J Med. 1984; 311:218-25.
[8]Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet. 1981; 2:823-7.
[9]Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation. 1983; 67:I32-41.
[10]Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study. J Intern Med Suppl. 1991; 734:35-42.
[11]Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol. 1993; 22:407-16.
[12]Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991; 83:422-37.
[13]Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol. 2004; 43:1780-7.
[14]Effects of prior betablocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol. 2003; 91:655-60.
[15]Cardioprotective effect of prior betablocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation. 2000; 102:166-72.
[16]The use of contrastenhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343:1445-53.
[17]Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation. 2007; 115:2909-16.
[18]The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol. 2011; 147:428-32.
[19]Ibanez B, Fuster V, Jiménez-Borreguero J, Badimon JJ. Lethal myocardial reperfusion injury: A necessary evil? Int J Cardiol. 2010. PMID: 21093938; Doi: 10.1016/j. ijcard.2010.10.056.
[20]Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005; 366:1622-32.
[21]Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation. 2003; 107:2577-82.
[22]The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002; 39:30-6.
[23]Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100:1992-2002.